The U.S. Food and Drug Administration issues the first emergency use authorization for a point-of-care Covid-19 diagnostic for the Cepheid Xpert Xpress SARS-CoV 2 test.
Cepheid is part of Danaher (NYSE:DHR).
The test will provide results within hours, rather than days like existing tests, said HHS Secretary Alex Azar.
Cepheid said the test has been designed to operate on any of its more than 23,000 automated GeneXpert Systems worldwide, with a detection time of ~45 minutes.
David S. Brown Enterprises has bolstered its Retail Leasing team with the recent hiring of Michael Gosnell
The Virginia law firm Gentry Locke is pleased to announce the promotion of Scott A. Stephenson to
Pessin Katz Law is pleased to announce that Attorney Adam E. Konstas has been elected to Member
Skanska, a leading global construction and development firm, announces that Gary Orton has joined the company as
For partnerships, content marketing or advertising inquiries, please contact Edwin through his LinkedIn Profile
Connect© Copyright 2026 citybuzz
